Research Faculty in Genomic Medicine
The Indiana University School of Medicine (IUSM) and the Indiana University Precision Health Initiative (PHI) seek to recruit outstanding candidates for multiple genomics-focused faculty positions within the following disease areas: Alzheimer's/neurodegeneration, breast cancer, diabetes/metabolic disease, myeloma/hematologic malignancies, and pediatric cancer.
Genomic Medicine is one of the specific areas being supported with substantial Precision Health Initiative resources. Co-led by the Chair of Genetics and Chair of Medicine, Drs. Tatiana Foroud and Mark Geraci, these positions will play a key role in creating the vision for research and clinical implementation of genomic medicine across one of the largest health systems in the nation. The Precision Health Initiative, was created with the bold goal of addressing major and large-scale health problems facing humanity through multidisciplinary teams of outstanding, innovative researchers. Precision Health was selected as the first recipient of funding from Indiana University Grand Challenges Program that is a $300 million research expansion across the entire University. The $120 million investment in Precision Health will be leveraged to recruit approximately 40 new, full-time faculty members on the Indiana University campuses in Bloomington and Indianapolis. Precision Health has supported the creation of new facilities, centers, and user platforms, including new gene editing and sequencing cores at the IUSM, and a Good Manufacturing Practice Cell Therapy (GMP) facility to produce cellular therapeutics. This investment will be leveraged with other IUSM resources to significant expand the scope of this initiative. Are Available in the Following Tracks:
In partnership with a number of academic departments and research centers, the Precision Health Initiative has assembled disease state teams in Alzheimer's/neurodegeneration, breast cancer, diabetes/metabolic disease, myeloma/hematologic malignancies, and pediatric cancer who are now seeking faculty with Genomics expertise. Qualified candidates will have an MD, PhD, or equivalent and a national reputation including a record of scholarship appropriate for appointment at the rank of Associate Professor and above.
- Alzheimer's/Neurodegeneration Genomics:
- Breast Cancer Genomics:
- Diabetes/Metabolic Disease Genomics:
- Myeloma/Hematologic Malignancies Genomics:
- Pediatric Cancer Genomics:
Indiana University is an Equal Opportunity, Affirmative Action employer committed to building a building a diverse learning environment and on supporting the professional development of ethnic minorities, women, and people with disabilities. All qualified applicants will receive consideration for employment without regard to age, color, disability, ethnicity, sex, gender identity, gender expression, genetic information, marital status, national origin, race, religion, sexual orientation, or veteran status.